Skip to content
Medives
Regulatory Guides intermediate May 15, 2026 · 12 min read

CE Marking for Chinese Medical Devices: What Importers Need to Know

A complete guide to CE marking requirements for medical devices manufactured in China. Covers EU MDR compliance, notified body selection, technical documentation, and common pitfalls.

By Medives Compliance Team
CE markingEU MDRnotified bodytechnical documentationcompliance

CE marking is mandatory for medical devices sold in the European Economic Area (EEA). For importers sourcing devices from China, understanding the CE marking process is critical to ensuring compliance and avoiding costly delays.

EU MDR 2017/745 Overview

The EU Medical Device Regulation (MDR) replaced the previous Medical Device Directive (MDD) in May 2021. Key changes include:

  • Stricter clinical evaluation requirements
  • Enhanced post-market surveillance obligations
  • New classification rules for certain device categories
  • Mandatory Unique Device Identification (UDI)
  • Increased transparency through EUDAMED database

Notified Body Selection

A notified body is an independent organization designated by an EU member state to assess conformity. Key considerations:

  • Availability: Post-MDR transition, many notified bodies have limited capacity. Book early — wait times can exceed 6 months.
  • Scope: Ensure the notified body covers your device classification and product codes.
  • Reputation: Bodies like TÜV SÜD, TÜV Rheinland, BSI, and DEKRA are widely recognized.
  • Cost: Budget $15,000–$80,000+ depending on device class and technical documentation complexity.

Technical Documentation Requirements

Your technical file must include:

  1. Device description and intended use
  2. Design and manufacturing information
  3. General safety and performance requirements (GSPR) checklist
  4. Risk management (ISO 14971)
  5. Clinical evaluation (MEDDEV 2.7/1 Rev 4 or MEDLINE MDCG 2020-6)
  6. Verification and validation testing
  7. Labeling and IFU samples
  8. Quality management system documentation (ISO 13485)

Common Pitfalls for Importers

  • Incomplete GSPR mapping: Every applicable requirement must be addressed with evidence.
  • Insufficient clinical data: Chinese manufacturers often under-prepare clinical evaluation reports.
  • Labeling non-compliance: EU MDR has specific labeling requirements (UDI, manufacturer info, EU representative).
  • Ignoring post-market obligations: Post-market clinical follow-up (PMCF) and vigilance reporting are mandatory.
  • Missing EU Authorized Representative: Non-EU manufacturers must appoint an EU-based authorized representative.

Step-by-Step Process

  1. Identify device classification (Class I, IIa, IIb, or III)
  2. Select and engage a notified body
  3. Prepare technical documentation
  4. Undergo conformity assessment
  5. Obtain CE certificate
  6. Prepare Declaration of Conformity
  7. Affix CE mark and place on EU market
  8. Maintain post-market surveillance

Timeline

  • Class I devices: 2–4 months
  • Class IIa devices: 4–8 months
  • Class IIb/III devices: 8–18 months

Start the process well before your target launch date. Delays in notified body review are common.

← Back to Knowledge Base